Supernus Pharmaceuticals, Inc. (SUPN)
55.58
+1.02
(+1.87%)
USD |
NASDAQ |
Mar 04, 16:00
56.00
+0.42
(+0.76%)
After-Hours: 04:46
Supernus Pharmaceuticals Price : 55.58 for March 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 189.94 |
| BridgeBio Pharma, Inc. | 66.54 |
| Corcept Therapeutics, Inc. | 35.69 |
| Catalyst Pharmaceuticals, Inc. | 24.69 |
| Cytokinetics, Inc. | 62.27 |
Price Related Metrics
| PS Ratio | 4.376 |
| Price to Book Value | 3.008 |
| Price to Free Cash Flow | 68.40 |
| Earnings Yield | -1.23% |
| Market Cap | 3.193B |